Democrats say fight continues after Supreme Court restores mifepristone mail access
Updated
Updated · The Guardian · May 4
Democrats say fight continues after Supreme Court restores mifepristone mail access
16 articles · Updated · The Guardian · May 4
Senate Democrat Chuck Schumer, Senator Jacky Rosen and Representative Pramila Jayapal welcomed the temporary ruling and urged permanent protection for the abortion pill.
They said Republicans and anti-abortion groups are still trying to curb access to medication abortion and warned against efforts to impose a nationwide abortion ban.
Since the 2022 Dobbs decision, mifepristone and misoprostol have become the most common US abortion method, making the case central to reproductive healthcare access.
When courts challenge scientific consensus on a drug, who should ultimately decide public access?
How could legal rulings on one medication impact the future training and location of medical professionals?
Emergency Supreme Court Order Pauses 5th Circuit Ban on Mail Delivery of Abortion Pill Mifepristone
Overview
On May 4, 2026, the U.S. Supreme Court issued an emergency order temporarily restoring nationwide access to the abortion medication mifepristone via telehealth and mail, pausing a recent ruling by the 5th Circuit Court that had reinstated an in-person requirement. This earlier ruling came after Louisiana and other groups challenged the FDA's 2023 rule that permanently allowed remote prescriptions and mail delivery. The 5th Circuit's decision caused confusion and threatened significant barriers for vulnerable patients and healthcare providers. The Supreme Court's order responds to emergency appeals by the drug manufacturers and sets a deadline for further legal responses, maintaining access until at least May 11, 2026.